title: Adverse prognostic impact of capsular incision at radical prostatectomy for Japanese men with clinically localized prostate cancer.
abstract: OBJECTIVE
  The objective of this study was to evaluate the significance of capsular incision (CI) at radical prostatectomy (RP) for men with prostate cancer.
  
  
  METHODS
  This study included 267 men who underwent RP without neoadjuvant therapy and were pathologically diagnosed as having organ-confined disease. CI was defined as exposing benign or malignant glands at the inked margin without documented extraprostatic extension.
  
  
  RESULTS
  Pathological examinations identified CI in 53 RP specimens (19.9%), while CI was not detected in the remaining 214 specimens (80.1%). The locations of CIs in RP specimens from these 53 patients were as follows: 39 (73.6%) at the apex, 11 (20.0%) at the anterior site, 4 (7.5%) at the posterior site and 12 (22.6%) at the bladder neck. The incidence of CI was significantly affected by surgical procedure, preoperative serum PSA and microvenous invasion in RP specimen. During the observation period of this study, biochemical recurrence occurred in 10 (18.9%) of the 53 with CI and 20 (9.3%) of the 214 without CI, and the biochemical recurrence-free survival in patients with CI was significantly poorer than those without CI. Furthermore, of several factors examined, biochemical recurrence was significantly associated with preoperative serum PSA, Gleason score, perineural invasion and capsular incision, among which only preoperative serum PSA appeared to be an independent predictor of biochemical recurrence.
  
  
  CONCLUSIONS
  Despite the lack of independent significance, the presence of CI has an adverse impact on biochemical outcome in patients undergoing RP for clinically localized prostate cancer.
authors.affiliation: Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
authors.forename: Masafumi
authors.initials: M
authors.lastname: Kumano
authors.forename: Hideaki
authors.initials: H
authors.lastname: Miyake
authors.forename: Mototsugu
authors.initials: M
authors.lastname: Muramaki
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Kurahashi
authors.forename: Atsushi
authors.initials: A
authors.lastname: Takenaka
authors.forename: Masato
authors.initials: M
authors.lastname: Fujisawa
mesh_terms: D000368:Aged; D006801:Humans; D007564:Japan; D008297:Male; D011379:Prognosis; D011468:Prostatectomy / Q000009:adverse effects* / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery*; D012189:Retrospective Studies
references.citation: J Urol. 1996 Apr;155(4):1344-7
references.pmid: 8632570
references.citation: J Clin Oncol. 2003 Feb 1;21(3):401-5
references.pmid: 12560426
references.citation: Int J Urol. 2002 Nov;9(11):635-40
references.pmid: 12534908
references.citation: J Urol. 2002 Feb;167(2 Pt 1):528-34
references.pmid: 11792912
references.citation: BJU Int. 2005 Feb;95(3):281-4
references.pmid: 15679778
references.citation: J Urol. 2000 Jun;163(6):1643-9
references.pmid: 10799152
references.citation: Cancer. 1999 Nov 1;86(9):1775-82
references.pmid: 10547551
references.citation: J Urol. 2003 Dec;170(6 Pt 1):2292-5
references.pmid: 14634399
references.citation: J Urol. 1998 Oct;160(4):1383-5
references.pmid: 9751359
references.citation: Urology. 2006 Aug;68(2):249-52
references.pmid: 16904428
references.citation: J Urol. 2004 Jul;172(1):119-23
references.pmid: 15201750
references.citation: Urol Clin North Am. 1996 Nov;23(4):651-63
references.pmid: 8948418
references.citation: J Urol. 2007 Oct;178(4 Pt 1):1306-10
references.pmid: 17698141
references.citation: Urology. 1996 Jul;48(1):80-90
references.pmid: 8693658
references.citation: J Urol. 1995 Nov;154(5):1818-24
references.pmid: 7563355
references.citation: Semin Urol Oncol. 2000 Feb;18(1):33-7
references.pmid: 10719928
references.citation: Eur Urol. 2006 Aug;50(2):199-201
references.pmid: 16624479
references.citation: Int J Urol. 2008 Aug;15(8):704-7; discussion 708
references.pmid: 18462349
references.citation: Urology. 2001 Nov;58(5):746-51
references.pmid: 11711353
references.citation: Semin Oncol. 1994 Oct;21(5):662-71
references.pmid: 7939754